^○Kiyokazu ATAKE¹, Yosuke KOSHIKAWA², Ryohei IGATA¹, Hirotaka TOMINAGA¹, Yuki KONISHI¹, Asuka KATSUKI¹, Hikaru HORI¹, Hiroki BANDO³, Shiho SAKAI², Keiichiro NISHIDA², Yuki KAGEYAMA⁴, Yoshiteru TAKEKITA², Reiji YOSHIMURA¹, Tadafumi KATO⁵, Masaki KATO² (1. Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan, 2. Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan, 3. Seishokai Sephiroth Hospital, Shiga, Japan, 4. Department of Neuropsychiatry, Osaka City University, Graduate School of Medicine, Osaka, Japan, 5. Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Saitama, Japan)

^○Nobuto TSUNEYAMA¹, Yutaro SUZUKI^{1, 2}, Hiroshi ARINAMI¹, Misuzu TAJIRI¹, Toshiyuki SOMEYA¹ (1. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 2. Suehirobashi Hospital)

^○Norio FURUKORI^{1, 7}, Takashi TSUBOI^{3, 7}, Naoto ADACHI², Yokihisa KUBOTA², Hitoshi UEDA², koji EDAGAWA², Eiichi KATSUMOTO², koji AZEKAWA², Eiichiro GOTO², Seiji HONGO², Kazuhira MIKI², Masaki KATO^{4, 7}, Reiji YOSHIMURA^{5, 7}, Toshiaki KIKUCHI^{6, 7}, Atsuo NAKAGAWA^{6, 7}, koichiro WATANABE^{3, 7} (1. Department of Psychiatry, Dokkyo Medical School, School of Medicine, Japan, 2. Japanese Association of Neuro-Psychiatric Clinics, 3. Department of Psychiatry, Kyorin University , 4. Department of Psychiatry, Kansai Medical School, 5. Department of Psychiatry, Dokkyo Medical School, , 6. Department of Psychiatry, Keio University, 7. Japanese Society of Neuropsychopharmacology)

^○Hiroshi ARINAMI¹, Yuutarou SUZUKI^{1, 2}, Misuzu TAJIRI¹, Nobuto TSUNEYAMA¹, Toshiyuki SOMEYA¹ (1. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences , 2. Suehirobashi Hospital)